Sofwave Receives FDA Clearance for Treating Upper Arm Skin Laxity
The FDA clearance of Sofwave to treat upper arm skin laxity comes as the American Society of Plastic Surgeons reports brachioplasty procedures grew 25% between 2019-2022.
The FDA clearance of Sofwave to treat upper arm skin laxity comes as the American Society of Plastic Surgeons reports brachioplasty procedures grew 25% between 2019-2022.
Researchers have discovered a naturally occurring protein that could lead to new therapies for preventing excessive scarring in patients during wound healing.